Affiliation:
1. Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2. Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, United States
3. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract
Curcumin quite possibly represents one of the most diverse therapeutic agents yet isolated from natural
sources. Therapeutic benefits of this extraordinary natural compound have been demonstrated during treatment of
a variety of diseases, including cancer, inflammatory processes, immunological disorders, Diabetes, and oxidative
stress often associated with hyperlipidemia. Due to its unique molecular chemical structure and functional groups,
curcumin may bind with and subsequently either inhibit or activate a variety of endogenous biomolecules, including
enzymes, receptors, signaling molecules, metals, transcription factors, and even certain proteins located in cell
membranes. In fact, curcumin exerts pharmacologically useful effects through non-covalent interactions with
biomolecules. With so many varied biological targets, curcumin (a polyphenol) elicits numerous pleiotropic effects,
which is therapeutically advantageous owing to the fact that many pathological disease states involve more
than one signaling pathway, receptor, protein/enzyme, or gene. In this paper, we will discuss the underlying
mechanisms responsible for the chemical interaction of curcumin with selected classes of biomolecules, rather
than attempt to provide an exhaustive list of each and every biomolecule with which curcumin may chemically
interact.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献